Orientations
WHO position paper on immunization to protect infants against respiratory syncytial virus disease
Recommendations on the use of maternal respiratory syncytial virus (RSV) vaccines and long-acting RSV monoclonal antibodies (mAbs) to prevent severe RSV disease in infants were issued by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization in September 2024 and endorsed by WHO thereafter. Evidence presented at that meeting, as well as SAGE’s conflict-of-interest assessment, can be accessed online. Separate policy recommendations on RSV vaccination for older adults will be issued at a future SAGE meeting. RSV vaccines for administration to infants older than 6 months and to toddlers are not yet licensed and are not discussed in this paper.
Auteurs
Langues
- Anglais
- Français
Année de publication
2025
Type
Orientations
Catégories
- Vaccins et dispositifs d'administration
Maladies
- RSV
Organisations
- Organisation Mondiale de la Santé (OMS)
Mots-clés
- SAGE
ADULT-PREGNANT
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| How to implement influenza vaccination of pregnant women | World Health Organization (WHO) | 2016 | Guidance | Anglais |
| Tailoring immunization programmes for seasonal influenza (TIP FLU) - A guide for promoting uptake of maternal influenza vaccination | WHO Regional Office for Europe (EURO) | 2017 | Guidance | Anglais |
| Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations | World Health Organization (WHO) | 2024 | Journal article | Anglais, Français |
| WHO position paper on immunization to protect infants against respiratory syncytial virus disease | World Health Organization (WHO) | 2025 | Guidance | Anglais, Français |
